Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100
- Authors
- Reck, M[Reck, M.]; Barlesi, F[Barlesi, F.]; Yang, JCH[Yang, J. C. -H.]; Westeel, V[Westeel, V.]; Felip, E[Felip, E.]; Ozguroglu, M[Ozguroglu, M.]; Dols, MC[Dols, M. Cobo]; Sullivan, R[Sullivan, R.]; Kowalski, D[Kowalski, D.]; Andric, Z[Andric, Z.]; Lee, DH[Lee, D. H.]; Sezer, A[Sezer, A.]; Shamrai, V[Shamrai, V.]; Szalai, Z[Szalai, Z.]; Wang, X[Wang, X.]; Xiong, H[Xiong, H.]; Jacob, N[Jacob, N.]; Mehr, KT[Mehr, K. Tadjalli]; Park, K[Park, K.]
- Issue Date
- Sep-2022
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- avelumab; NSCLC; first-line
- Citation
- JOURNAL OF THORACIC ONCOLOGY, v.17, no.9, pp.S39 - S39
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF THORACIC ONCOLOGY
- Volume
- 17
- Number
- 9
- Start Page
- S39
- End Page
- S39
- ISSN
- 1556-0864
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.